Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be announcing earnings results this Tuesday morning. Here’s what you need to know.
Quest beat analysts’ revenue expectations by 3.3% last quarter, reporting revenues of $2.82 billion, up 13.2% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and full-year revenue guidance slightly topping analysts’ expectations.
Is Quest a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Quest’s revenue to grow 5.1% year on year to $2.75 billion, slowing from the 14.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.36 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Quest has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.9% on average.
Looking at Quest’s peers in the healthcare providers & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. DaVita delivered year-on-year revenue growth of 9.9%, beating analysts’ expectations by 3.2%, and Cardinal Health reported revenues up 18.8%, topping estimates by 1.2%. DaVita traded up 21.2% following the results while Cardinal Health was also up 9.4%.
Read our full analysis of DaVita’s results here and Cardinal Health’s results here.
Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.1% on average over the last month. Quest is up 9.1% during the same time and is heading into earnings with an average analyst price target of $199.31 (compared to the current share price of $190.02).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
/Alphabet%20(Google)%20Image%20by%20Piotr%20Swat%20via%20Shutterstock.jpg)